Status:

UNKNOWN

Diagnostic Study of Huami Smart Wearable Device

Lead Sponsor:

Peking University First Hospital

Collaborating Sponsors:

Anhui Huami Information Technology Co., Ltd.

Conditions:

Oxygen Saturation

Eligibility:

All Genders

18-85 years

Brief Summary

This is a cross-sectional diagnostic study. In this study, wrist oxygen saturation (SwO2) will be measured by Huami smart wearable device, SpO2 of pulse oxygen saturation monitor with medical device r...

Detailed Description

This is a cross-sectional diagnostic study. 30\~50 inpatient aged 18~85y with SaO2/ SpO2 between 80%∽100% will be recruited from the Department of Respiratory and Critical Care of Peking University Fi...

Eligibility Criteria

Inclusion

  • Inpatients in the Department of Respiratory and Critical Care at Peking University First Hospital
  • Oxygen intake or no oxygen intake when enrolled: 80%≤SaO2/SpO2≤100%
  • Age between 18 and 85 years, either gender
  • COHb\<3%, MetHb\<2%;
  • Sign an informed consent or sign an informed consent by a legally authorized representative;
  • Be willing and able to follow the research program.

Exclusion

  • current smokers or those exposed to high levels of carbon monoxide.
  • critically ill patients who are in a state of shock, resulting in peripheral circulation disorders.
  • Patients with hypothermia below 35°C.
  • Patients with bilateral wrist and hand oedema, soft tissue damage to the wrist, skin incomplete and unable to wear a watch/ bracelet.
  • Vascular blood supply abnormalities of both upper limbs (occlusion, thrombosis, post-trauma, etc.), which affects the test results
  • Patients with bilateral upper extremity pigmentation affecting the test results;
  • Patients with limb mobility impairment due to severe cerebrovascular disease sequelae.
  • Patients with severe mental system disease that makes it impossible to cooperate with the researchers.

Key Trial Info

Start Date :

May 29 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2020

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04429906

Start Date

May 29 2020

End Date

June 30 2020

Last Update

June 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking University First Hospital

Beijing, Beijing Municipality, China, 100034